ArticleInternational urogynecology journal2026
Patient-Reported Long-Term Outcomes of Laparoscopic Sacrocolpopexy.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisLaparoscopic mesh sacrocolpopexy (LSC) is an effective treatment option for post-hysterectomy vault prolapse. The use of nonabsorbable mesh can be associated with adverse events (AEs) although long-term studies are lacking. This study aimed to report the rate of mesh-related AEs following LSC.
methodsThis is a cross-sectional postal questionnaire study of women who underwent LSC from 2011 to 2023 at a tertiary UK centre. Participants were identified through surgical databases.
resultsThe primary outcome was patient-reported mesh complication requiring reoperation. Secondary outcomes included use of pain services, Patient Global Impression of Improvement (PGI-I) scores and reoperation for prolapse or incontinence. There was a 58% (n = 334) completion rate from 574 eligible women identified. The median follow-up was 116 months (range 11-221). The rate of reoperation for a mesh-related AE was 1.5% (n = 5) and 3% (n = 10) were under the care of a pain specialist due to mesh-related pain. When asked how their prolapse symptoms were compared to pre-LSC, 5.7% reported them as 'very much worse' or 'much worse', compared to 70.4% who rated their symptoms 'very much better' or 'much better'. The operative rate for recurrent prolapse was 12% (n = 41) and for stress incontinence 7% (n = 23).
conclusionsAt nearly 10 years following LSC, the risk of reoperation for a mesh-related AE in this large cross-sectional study is only 1.5% and rates of chronic pain service use are low. Reassuringly, most women report ongoing satisfaction with prolapse symptoms and rates of reoperation appear favourable. These data will support the counselling of women in the UK seeking abdominal mesh surgical treatment for post-hysterectomy vault prolapse.
Indexed as
Identifiers
41081818What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.